Skip to content

Medical-device intelligence

NAJ: Agents, Embolic, For Treatment Of Uterine Fibroids

FDA product code NAJ: Agents, Embolic, For Treatment Of Uterine Fibroids. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NAJ
FDA device name
Agents, Embolic, For Treatment Of Uterine Fibroids
Device class
2
Regulation number
870.3300
Medical specialty
Cardiovascular
Review panel
OB

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore cardiovascular records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 1 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Nov 22, 2002 to Dec 21, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NAJ · Agents, Embolic, For Treatment Of Uterine Fibroids81

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
Bearing nsPVA Express™K233813 · NAJMerit Medical Systems, Inc.510(k)Dec 21, 2023FDA decision date
CalliSpheres Embolic Microspheres, 8Spheres Embolic MicrospheresK173871 · NAJSuzhou Hengrui Callisyn Biomedical Co., Ltd.510(k)Sep 17, 2018FDA decision date
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERESK133447 · NAJCelonova Biosciences, Inc.510(k)Feb 24, 2014FDA decision date
BEARING NSPVA EMBOLIZATION PARTICLESK130259 · NAJMerit Medical Systems, Inc.510(k)Jun 7, 2013FDA decision date
CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321K100663 · NAJBoston Scientific Corporation510(k)Apr 16, 2010FDA decision date
Boston Scientific, Contour SE Microspheres, for tumor treatment. UPN Codes: Description: M001761101 Contour SE/100-300/1mL/2vials M001761122 Co…Z-2109-2009 · NAJBoston Scientific CorporationRecallSep 15, 2009FDA classification date
COOK INCORPORATED POLYVINYL ALCOHOL FOAM EMBOLIZATION PARTICLESK081768 · NAJCook Incorporated510(k)Dec 23, 2008FDA decision date
CONTOUR EMBOLI PVA AND FASTRACKER-325 INFUSION CATHETERK030966 · NAJBoston Scientific Corp510(k)Sep 23, 2003FDA decision date
EMBOSPHERE MICROSPHERES AND EMBOGOLD MICROSPHERES FOR USE IN UTERINE FIBROID EMBOLIZATIONK021397 · NAJBiosphere Medical, Inc.510(k)Nov 22, 2002FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗